跳至主要内容
临床试验/CTRI/2023/10/058275
CTRI/2023/10/058275尚未招募2/3 期

Study of add on effect of Baladi Ghrita along with ferrous ascorbate in themanagement of Mridbhakshanjanya Pandu- A Randomized, Controlled, Clinical trial.

DrKiran Laxmanrao Kudmate1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年6月10日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Study of add on effect of Baladi Ghrita in the management of Mridbhakshanjanya Pandu

研究概览

简要总结

This study is Randomized, Open labelled, Controlled, Clinical study of efficacy of add on effect Baladi Ghrita along with ferrous ascorbate in Mridbhakshanjanya Pandu when given orally for two months and follow up on 31st and 60th day. This study is conducted as PG course at

single center. The primary outcome is to Study the add on effect of Baladi Ghrita in the management of Mridbhakshanjanya Pandu

when given orally along with ferrous ascorbate on Pallor, Hb% , MCV, RDW-CV.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
2.00 Year(s) 至 6.00 Year(s)(—)
性别
All

入选标准

  • Patient will be selected irrespective of their gender, caste and socioeconomic status.
  • Patient’s age group between 2-6 years.
  • Hb% >8 gm/dl and <11gm/dl.

排除标准

  • Patient having any major systemic illness.
  • Patients below 2 year and above 6 years.
  • Patients with defective iron absorption in condition like gastrostomy, gastro-jejunostomy.
  • Anemia due to chronic illness like malaria, T.B, Leukemia, etc .
  • K/C/O Congenital anomalies, ADHD, Mentally retarded.
  • Hb% <8 gm/dl and >11 gm/dl.

结局指标

主要结局

Study of add on effect of Baladi Ghrita in the management of Mridbhakshanjanya Pandu

时间窗: 4 Weeks

when given orally along with ferrous ascorbate on Pallor, Hb% , MCV, RDW-CV

时间窗: 4 Weeks

次要结局

  • To study the clinical appearance of Mridbhakshanjany Pandu occurring in(Children according to both Ayurvedic & modern point of view.)

研究者

发起方
DrKiran Laxmanrao Kudmate
申办方类型
Other [[self]]

研究点 (1)

Loading locations...

相似试验